054670 — Daehan Nupharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapContrarian

Annual balance sheet for Daehan Nupharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20,360	21,494	28,550	22,960	36,697
Net Total Accounts Receivable
Net Total Receivables	31,592	32,189	37,569	40,331	39,901
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	68,702	76,033	102,641	98,485	115,354
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	38,570	46,294	46,978	54,313	85,042
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	132,733	157,643	169,359	176,927	221,285
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	51,119	45,049	58,584	61,758	71,881
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	73,494	75,178	66,400	67,571	95,846
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	59,239	82,465	102,959	109,356	125,439
Total Liabilities & Shareholders' Equity	132,733	157,643	169,359	176,927	221,285
Total Common Shares Outstanding